THERIVA BIOLOGICS INC (TOVX) Fundamental Analysis & Valuation

NYSEARCA:TOVX • US87164U5083

Current stock price

0.2189 USD
0 (-0.5%)
Last:

This TOVX fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. TOVX Profitability Analysis

1.1 Basic Checks

  • In the past year TOVX has reported negative net income.
  • In the past year TOVX has reported a negative cash flow from operations.
  • TOVX had negative earnings in each of the past 5 years.
  • TOVX had a negative operating cash flow in each of the past 5 years.
TOVX Yearly Net Income VS EBIT VS OCF VS FCFTOVX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -10M -20M -30M

1.2 Ratios

  • TOVX has a worse Return On Assets (-66.03%) than 62.24% of its industry peers.
  • Looking at the Return On Equity, with a value of -164.14%, TOVX is doing worse than 65.90% of the companies in the same industry.
Industry RankSector Rank
ROA -66.03%
ROE -164.14%
ROIC N/A
ROA(3y)-57.27%
ROA(5y)-46.53%
ROE(3y)-114.97%
ROE(5y)-83.41%
ROIC(3y)N/A
ROIC(5y)N/A
TOVX Yearly ROA, ROE, ROICTOVX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -200 -400 -600 -800 -1K

1.3 Margins

  • TOVX does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
TOVX Yearly Profit, Operating, Gross MarginsTOVX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. TOVX Health Analysis

2.1 Basic Checks

  • Compared to 1 year ago, TOVX has more shares outstanding
  • TOVX has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, TOVX has a worse debt to assets ratio.
TOVX Yearly Shares OutstandingTOVX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M
TOVX Yearly Total Debt VS Total AssetsTOVX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M

2.2 Solvency

  • Based on the Altman-Z score of -14.71, we must say that TOVX is in the distress zone and has some risk of bankruptcy.
  • With a Altman-Z score value of -14.71, TOVX is not doing good in the industry: 80.54% of the companies in the same industry are doing better.
  • TOVX has a Debt/Equity ratio of 0.11. This is a healthy value indicating a solid balance between debt and equity.
  • Looking at the Debt to Equity ratio, with a value of 0.11, TOVX is doing worse than 62.62% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF N/A
Altman-Z -14.71
ROIC/WACCN/A
WACCN/A
TOVX Yearly LT Debt VS Equity VS FCFTOVX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M 40M 60M

2.3 Liquidity

  • TOVX has a Current Ratio of 1.74. This is a normal value and indicates that TOVX is financially healthy and should not expect problems in meeting its short term obligations.
  • TOVX's Current ratio of 1.74 is on the low side compared to the rest of the industry. TOVX is outperformed by 79.19% of its industry peers.
  • TOVX has a Quick Ratio of 1.74. This is a normal value and indicates that TOVX is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 1.74, TOVX is doing worse than 78.03% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.74
Quick Ratio 1.74
TOVX Yearly Current Assets VS Current LiabilitesTOVX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. TOVX Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 79.11% over the past year.
EPS 1Y (TTM)79.11%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%92.48%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • The Earnings Per Share is expected to grow by 25.53% on average over the next years. This is a very strong growth
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y58.94%
EPS Next 2Y25.53%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
TOVX Yearly Revenue VS EstimatesTOVX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2028 2029 2030 2031 2032 2033 100M 200M 300M 400M
TOVX Yearly EPS VS EstimatesTOVX Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 -1K -2K -3K -4K

More info and screens

Find the best growth stocksShow best growing peers

1

4. TOVX Valuation Analysis

4.1 Price/Earnings Ratio

  • TOVX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for TOVX. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
TOVX Price Earnings VS Forward Price EarningsTOVX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
TOVX Per share dataTOVX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -1 -2 -3 -4

4.3 Compensation for Growth

  • TOVX's earnings are expected to grow with 25.53% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y25.53%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. TOVX Dividend Analysis

5.1 Amount

  • No dividends for TOVX!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

TOVX Fundamentals: All Metrics, Ratios and Statistics

THERIVA BIOLOGICS INC

NYSEARCA:TOVX (3/26/2026, 2:30:03 PM)

0.2189

0 (-0.5%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)03-04
Earnings (Next)05-12
Inst Owners3.68%
Inst Owner Change189.27%
Ins Owners0%
Ins Owner Change0%
Market Cap10.05M
Revenue(TTM)N/A
Net Income(TTM)-25.25M
Analysts80
Price Target7.14 (3161.76%)
Short Float %17.51%
Short Ratio0.72
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)23.88%
EPS NQ rev (3m)23.88%
EPS NY rev (1m)0%
EPS NY rev (3m)53.6%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.65
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-4.06
EYN/A
EPS(NY)-1.55
Fwd EYN/A
FCF(TTM)-0.36
FCFYN/A
OCF(TTM)-0.36
OCFYN/A
SpS0
BVpS0.34
TBVpS-0.09
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -66.03%
ROE -164.14%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-57.27%
ROA(5y)-46.53%
ROE(3y)-114.97%
ROE(5y)-83.41%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 32.41%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.74
Quick Ratio 1.74
Altman-Z -14.71
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)60.92%
Cap/Depr(5y)65.44%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)79.11%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%92.48%
EPS Next Y58.94%
EPS Next 2Y25.53%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-23.8%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y1.38%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y1.58%
OCF growth 3YN/A
OCF growth 5YN/A

THERIVA BIOLOGICS INC / TOVX Fundamental Analysis FAQ

What is the ChartMill fundamental rating of THERIVA BIOLOGICS INC (TOVX) stock?

ChartMill assigns a fundamental rating of 1 / 10 to TOVX.


What is the valuation status for TOVX stock?

ChartMill assigns a valuation rating of 1 / 10 to THERIVA BIOLOGICS INC (TOVX). This can be considered as Overvalued.


How profitable is THERIVA BIOLOGICS INC (TOVX) stock?

THERIVA BIOLOGICS INC (TOVX) has a profitability rating of 0 / 10.


How financially healthy is THERIVA BIOLOGICS INC?

The financial health rating of THERIVA BIOLOGICS INC (TOVX) is 1 / 10.